DFCM
ANAB icon

Dark Forest Capital Management’s AnaptysBio ANAB Stock Holding History

Dark Forest Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,360
Closed -$61K – 1244
2021
Q2 		$61K Buy
+2,360
New +$56.6K 0.03% 416

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dark Forest Capital Management's ANAB Position: Q3 2021 in Review

Dark Forest Capital Management sold out of AnaptysBio (ANAB) in Q3 2021, closing a stake of 2,360 shares — an estimated $61K sold.

Dark Forest Capital Management first reported a position in ANAB in Q2 2021 and held it in 1 quarter. The position peaked at $61K in Q2 2021. 127 funds tracked by Wall St. Rank hold ANAB as of Q3 2021.

  • Dark Forest Capital Management reported no remaining AnaptysBio position as of Q3 2021 after selling out during the quarter.
  • Dark Forest Capital Management sold 2,360 AnaptysBio shares in Q3 2021, an estimated $61K.
  • Dark Forest Capital Management first reported a position in AnaptysBio in Q2 2021 and held it in 1 quarter.
  • Dark Forest Capital Management's AnaptysBio position peaked at $61K in Q2 2021.
  • 127 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2021.

Based on Dark Forest Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.